Home Industry Updates

Industry Updates

Community pharmacy to administer Covid-19 vaccination

Australia’s 5,800 community pharmacies are set to play a vital role in the vaccination of the Australian population against Covid-19. National President of the Pharmacy...

Gut microbiome may influence Covid-19 severity

The variety and volume of bacteria in the gut, known as the microbiome, may influence the severity of Covid-19 as well as the magnitude...

APP2021 exhibitor and delegate grant funding secured

The Pharmacy Guild of Australia, Queensland Branch, has been successful in securing grant support through Austrade for exhibitors and attendees to the Australian Pharmacy...

Antibiotic-resistance breakthrough 

A major risk of being hospitalised is catching a bacterial infection. Hospitals, especially areas including intensive care units and surgical wards, are teeming with bacteria,...

Aussies want Covid-19 information to be clear and concise

A new YouGov poll has found that Australians fear unchecked misinformation online could derail Covid-19 vaccination efforts and want to see greater transparency about...

Software company integrates natural medicines database to platform

In what is said to be a first-of-its-kind solution in Australia, the software company, MedicalDirector is set to integrate the globally recognised Natural Medicines...

Call for suitable healthcare services for older Aboriginals

A new study has found that the majority of older Aboriginal Australians are avoiding mainstream health and aged care services as they feel safer...

Don’t put off your GP visit

The Royal Australian College of General Practitioners (RACGP) is urging the community to continue accessing required healthcare despite spiking numbers of Covid-19 in some...

Community pharmacies remain open amid lockdown

As Greater Brisbane enters its third day of the three-day snap lockdown Queensland Pharmacy Guild Branch President, Professor Trent Twomey reminds residents that community...

Keeping rheumatoid arthritis in check 

Delaying treatment for autoimmune conditions like rheumatoid arthritis can lead to increased permanent joint damage and disability. New information and resources from the Targeted Therapies...

TGA announces OTC access for low dose CBD

The Therapeutic Goods Administration (TGA) announced on 15 December a final decision to down-schedule certain low dose cannabidiol (CBD) preparations from Schedule 4 (Prescription...

New study to determine genomic risk of coronary artery disease

A new Baker Institute study could lead to fundamental changes in the way we diagnose, treat and prevent coronary artery disease. Researchers are aiming to...
312FansLike
763FollowersFollow
44FollowersFollow
X